Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philip A. Poole-Wilson is active.

Publication


Featured researches published by Philip A. Poole-Wilson.


American Journal of Cardiology | 1994

Abnormal autonomic control of the cardiovascular system in syndrome X

Giuseppe Rosano; Piotr Ponikowski; Stamatis Adamopoulos; Peter Collins; Philip A. Poole-Wilson; Andrew J.S. Coats; Juan Carlos Kaski

Anomalies of autonomic control of the coronary circulation may play a role in the development of syndrome X (angina pectoris, ischemic-appearing results on exercise test, and normal coronary arteriograms). Twenty-six patients with syndrome X and 20 healthy sex- and age-matched control subjects were studied by means of analysis of heart rate variability during 24-hour Holter monitoring. Spectral and nonspectral parameters of heart rate variability were investigated. Mean heart rate was similar in patients with syndrome X and in control subjects. Patients with syndrome X had significantly lower standard deviation of all normal RR intervals, a lower percentage of adjacent normal RR intervals > 50 ms in difference (126.4 +/- 22 vs 149 +/- 43 ms, p < 0.05; 6.3 +/- 4 vs 11.2 +/- 7%, p < 0.05; respectively), and a trend toward lower values of time-domain parameters. Lower values of total power and low frequency were also observed in patients with syndrome X (1273 +/- 693 vs 1790 +/- 989 ms2, p < 0.05; 406 +/- 176 vs 729 +/- 455 ms2, p < 0.01, respectively). An inverse correlation between heart rate and measures of heart rate variability was found in syndrome X but not in control subjects. High- and low-frequency power showed a similar circadian pattern in syndrome X patients and control subjects. Patients and control subjects were then allocated into 2 groups according to the median RR duration: syndrome X1 and control 1 with high mean heart rate, and syndrome X2 and control 2 with low mean heart rate.(ABSTRACT TRUNCATED AT 250 WORDS)


American Journal of Cardiology | 1995

Abnormal uptake and washout of thallium-201 in patients with syndrome X and normal-appearing scans

Giuseppe Rosano; Nicholas S. Peters; Juan Carlos Kaski; Sophie I. Mavrogeni; Peter Collins; Richard S. Underwood; Philip A. Poole-Wilson

Abstract In conclusion, visual analysis of thallium-201 scans is of limited value in patients with syndrome X. Analysis of uptake and washout of thallium-201 may be useful in investigating the mechanism of chest pain in patients with syndrome X and normal-appearing thallium-201 scans. Additional information provided by this method of analysis may prove clinically useful.


Deutsche Medizinische Wochenschrift | 2005

Adherence to guidelines in CHF therapy in Germany - a subgroup analysis of the Mahler survey

Markus Flesch; Michel Komajda; Pablo Lapuerta; N. Hermans; C Le Pen; [No Value] Gonzales-Juanatey; D. J. Van Veldhuisen; Luigi Tavazzi; Philip A. Poole-Wilson; Erland Erdmann


Deutsche Medizinische Wochenschrift | 2005

Leitliniengerechte Herzinsuffizienzbehandlung in Deutschland

Markus Flesch; Michel Komajda; Pablo Lapuerta; N. Hermans; C Le Pen; J.-R. Gonzáles-Juanatey; D. J. Van Veldhuisen; Luigi Tavazzi; Philip A. Poole-Wilson; Erland Erdmann


Deutsche Medizinische Wochenschrift | 2005

Leitliniengerechte Herzinsuffizienzbehandlung in Deutschland : Ergebnisse der MAHLER-Studie

Markus Flesch; Michel Komajda; Pablo Lapuerta; N. Hermans; C Le Pen; J.-R. Gonzáles-Juanatey; D. J. Van Veldhuisen; Luigi Tavazzi; Philip A. Poole-Wilson; Erland Erdmann


Archive | 2011

Deficiency: FERRIC-HF: A Randomized, Controlled, Observer-Blinded Trial Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and

Piotr Ponikowski; Waldemar Banasiak; Constantinos G. Missouris; Philip A. Poole-Wilson; M. Slater; Michael Roughton; Gabor Foldes; Thomas Thum; Jacek Majda; Darlington O. Okonko; Agnieszka Grzeslo; Tomasz Witkowski; Amit K. J. Mandal


Archive | 2011

in Seniors With Heart Failure) (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization and Preserved Left Ventricular Ejection Fraction: Data From SENIORS Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired

M. Flather; Michael Roughton; Andrew Coats; Philip A. Poole-Wilson; Dirk J. van Veldhuisen; Alain Cohen-Solal; Michael Böhm; Stefan D. Anker


Archive | 2010

body composition, anabolic deficiency, cytokine and neurohormonal activation Deficient insulin-like growth factor I in chronic heart failure predicts altered

James Hooper; Philip A. Poole-Wilson; Andrew Coats; Stefan D. Anker; Josef Niebauer; Claus-Dieter Pflaum; Andrew L. Clark; Christian J. Strasburger


Archive | 2009

Linee guida ESC per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico 2008 = Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008

Kenneth Dickstein; Alain Cohen-Solal; G. Filippatos; John J.V. McMurray; P. Ponikowski; Philip A. Poole-Wilson; Anna Strömberg; D. J. Van Veldhuisen; Dan Atar; Arno W. Hoes; Andre Keren; Alexander Mebazaa; Markku S. Nieminen; Silvia G. Priori; Karl Swedberg


Value in Health | 2003

PCV24 THE MAHLER STUDY: DIFFERENCES IN RESOURCE USE FOR THE MANAGEMENT OF CHRONIC HEART FAILURE ACROSS 6 EUROPEAN COUNTRIES

H Lilliu; C Le Pen; Pablo Lapuerta; José Ramón González-Juanatey; D Van Veldhuisen; Erland Erdmann; Philip A. Poole-Wilson; Luigi Tavazzi; N. Hermans; G Priol; Michel Komajda

Collaboration


Dive into the Philip A. Poole-Wilson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Roughton

Royal College of Physicians

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Coats

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge